Search results (207)
« Back to News
New technology helps decode the genetic changes behind disease
7 Oct, 2026
Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.
Everyday DNA damage reveals a hidden weakness in some cancers
28 Sep, 2026
Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
Professor Marella de Bruijn receives MRC Programme Award
11 Sep, 2026
Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.
Professor Bethan Psaila wins ISEH Janet Rowley Award
1 Sep, 2026
Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.
Professor KJ Patel awarded Royal Society Buchanan Medal
1 Sep, 2026
Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.
A summer of science and engagement
26 Aug, 2026
- Centre for Computational Biology
- Department of Oncology
- MRC MHU
- MRC TIDU
- NDM
- NDWRH
- PPIE
- Paediatrics
- RDM
This summer, researchers at the MRC WIMM have taken part in a variety of public engagement activities, leading a stand at Cheltenham Science Festival and welcoming students for the Institute's summer work experience programme.
New personalised therapy targets chronic blood cancer
2 Jul, 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
WIMM Day 2026: connecting people, ideas and scientific discovery
26 Jun, 2026
- Centre for Computational Biology
- Department of Oncology
- Grants & Awards
- MRC MHU
- MRC TIDU
- NDCN
- NDM
- NDWRH
- RDM
On Tuesday 23rd June, the MRC WIMM community came together at Saïd Business School for the Institute's annual away day, sharing research, professional achievements and much more.
Professor KJ Patel awarded major European Research Council Advanced Grant
23 Jun, 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
Professor Adam Mead joins Oxford Cancer leadership team
15 Jun, 2026
Congratulations to Adam Mead, who has been appointed Director of Oxford Cancer. Professor Mead joins Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.
Study reveals blood stem cells can ‘remember’ inflammation
27 May, 2026
Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May, 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.
Deputy Directors of the MRC Weatherall Institute of Molecular Medicine
7 May, 2026
Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.
Congratulations to our new Associate Professors
7 May, 2026
MRC WIMM is delighted to announce the conferment of two new Associate Professorships. Our newly appointed Associate Professors have been recognised for their outstanding contributions to research, teaching, and citizenship within the University and beyond.
2026 Genome Engineering Forum brings together Oxford research community
20 Apr, 2026
The Genome Engineering, Virus Production and Transgenics Facility at the MRC Weatherall Institute of Molecular Medicine (WIMM), together with the MRC Mary Lyon Centre, recently organised the 2026 Genome Engineering Forum at the MRC WIMM, bringing together over 100 academic researchers, staff and students from across Oxfordshire.